BioNexus Gene Lab Corp - BGLC

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q3 2026 · Compare: Q2 2026
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
HRT FINANCIAL LP History Closed out 0 0 — 0.0% — -14,283 -100.0% Q3 2026 Nov 13, 2026
UBS Group AG History Added to 306 0 — — — +205 202.97% Q3 2026 Nov 10, 2026
Caitong International Asset Management Co., Ltd History Added to 137 0 — — — +136 13600.0% Q3 2026 Oct 29, 2026
Tower Research Capital LLC (TRC) History New 12 0 — — — +12 New Q3 2026 Nov 16, 2026
JPMORGAN CHASE & CO History New 2 0 — — — +2 New Q3 2026 Nov 12, 2026